ZA201203616B - Pharmaceutical compositin and preparation method thereof - Google Patents

Pharmaceutical compositin and preparation method thereof

Info

Publication number
ZA201203616B
ZA201203616B ZA2012/03616A ZA201203616A ZA201203616B ZA 201203616 B ZA201203616 B ZA 201203616B ZA 2012/03616 A ZA2012/03616 A ZA 2012/03616A ZA 201203616 A ZA201203616 A ZA 201203616A ZA 201203616 B ZA201203616 B ZA 201203616B
Authority
ZA
South Africa
Prior art keywords
preparation
compositin
pharmaceutical
pharmaceutical compositin
Prior art date
Application number
ZA2012/03616A
Inventor
Dong-Yeon Kim
Jae Soo Shin
Hyun Tae Lim
Dae Sung Kim
Seung Hyoun Lee
Jun Ho Sung
Original Assignee
Il-Yang Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il-Yang Pharmaceutical Co Ltd filed Critical Il-Yang Pharmaceutical Co Ltd
Publication of ZA201203616B publication Critical patent/ZA201203616B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/417Imidazole-alkylamines, e.g. histamine, phentolamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA2012/03616A 2012-03-27 2012-05-17 Pharmaceutical compositin and preparation method thereof ZA201203616B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120031154A KR101956586B1 (en) 2012-03-27 2012-03-27 Pharmaceutical composition and preparation method thereof

Publications (1)

Publication Number Publication Date
ZA201203616B true ZA201203616B (en) 2013-01-30

Family

ID=49260622

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/03616A ZA201203616B (en) 2012-03-27 2012-05-17 Pharmaceutical compositin and preparation method thereof

Country Status (9)

Country Link
KR (1) KR101956586B1 (en)
AR (1) AR086951A1 (en)
BR (1) BR102012027409B1 (en)
IL (1) IL234614B (en)
SA (1) SA112330839B1 (en)
TW (1) TWI597063B (en)
UA (1) UA110882C2 (en)
WO (1) WO2013147414A1 (en)
ZA (1) ZA201203616B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101369584B1 (en) 2011-04-19 2014-03-06 일양약품주식회사 Phenyl-isoxazol derivatives and preparation process thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU2005290583A1 (en) * 2004-10-01 2006-04-13 Eisai R & D Management Co., Ltd. Fine particles-containing composition and manufacturing method therefor
KR100674813B1 (en) * 2005-08-05 2007-01-29 일양약품주식회사 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
KR20100021321A (en) * 2008-08-14 2010-02-24 일양약품주식회사 Process for the preparation of n-phenyl-2-pyrimidine-amine derivatives
US20100278921A1 (en) * 2009-04-30 2010-11-04 Fischer Cristina M Solid oral formulation of abt-263

Also Published As

Publication number Publication date
WO2013147414A1 (en) 2013-10-03
KR101956586B1 (en) 2019-03-11
BR102012027409A2 (en) 2016-07-05
AR086951A1 (en) 2014-02-05
TWI597063B (en) 2017-09-01
UA110882C2 (en) 2016-02-25
TW201338780A (en) 2013-10-01
KR20130109425A (en) 2013-10-08
SA112330839B1 (en) 2015-08-19
IL234614B (en) 2018-02-28
BR102012027409B1 (en) 2021-06-22

Similar Documents

Publication Publication Date Title
IL252566B (en) Pharmaceutical compositions and methods
EP2884394A4 (en) Administration system and administration method
EP2937072A4 (en) Medicine preparation method and medicine preparation apparatus
EP2813833A4 (en) Thin section preparation device and thin section preparation method
HK1203815A1 (en) Pharmaceutical compositions and methods for their preparation
EP2806084A4 (en) Forming device and construction method using forming device
HK1205095A1 (en) Methods and intermediates for preparing pharmaceutical agents
SG11201408326TA (en) Preparation method for perfluoro-2-methyl-3-pentanone and intermediate
HK1202857A1 (en) Benzodioxole derivative and preparation method and use thereof
HK1210465A1 (en) Fluoropicolinoyl fluorides and processes for their preparation
EP2807093A4 (en) Material delivery method and system
EP2837624A4 (en) 4-substituent-2-hydroxylmorpholine-3-one and preparation method thereof
EP2895168A4 (en) Tetrandrine pharmaceutical formulations and method
SG11201500474PA (en) Nutriculture member and nutriculture method
EP2907817A4 (en) Method for preparing cu-btc and nano-cu-btc
EP2853555A4 (en) Film and preparation method thereof
GB2501226B (en) Construction setting out apparatus and method
GB201208315D0 (en) Pharmaceutical methods and compositions
GB201222820D0 (en) Woolscouring method and composition
GB201206859D0 (en) Method and composition
ZA201203616B (en) Pharmaceutical compositin and preparation method thereof
EP2865272A4 (en) Plant-disease-control composition and plant-disease-control method
PL398018A1 (en) New diacylo-sn-glycero-3-phosphocholine and process for the preparation thereof
PL398021A1 (en) New diacylo-sn-glycero-3-phosphocholine and process for the preparation thereof
ZA201408723B (en) Emulsion for pharmaceutical use and method for the production thereof